GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 94 filers reported holding GOSSAMER BIO INC in Q2 2024. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $165,298 | +22.1% | 140,083 | +24.2% | 0.00% | 0.0% |
| Q2 2023 | $135,358 | -56.9% | 112,798 | -54.8% | 0.00% | -50.0% |
| Q1 2023 | $314,133 | -11.4% | 249,312 | +52.6% | 0.00% | 0.0% |
| Q4 2022 | $354,576 | -94.2% | 163,399 | -68.1% | 0.00% | -94.1% |
| Q3 2022 | $6,131,000 | +1031.2% | 511,791 | +691.1% | 0.03% | +1033.3% |
| Q2 2022 | $542,000 | -35.2% | 64,696 | -32.8% | 0.00% | -57.1% |
| Q1 2022 | $836,000 | +29.8% | 96,262 | +69.0% | 0.01% | +16.7% |
| Q4 2021 | $644,000 | -31.7% | 56,958 | -24.1% | 0.01% | -50.0% |
| Q3 2021 | $943,000 | +727.2% | 75,018 | +432.2% | 0.01% | +1100.0% |
| Q2 2021 | $114,000 | -71.4% | 14,096 | -67.3% | 0.00% | -80.0% |
| Q1 2021 | $398,000 | +161.8% | 43,054 | +173.1% | 0.01% | +150.0% |
| Q4 2020 | $152,000 | -74.8% | 15,765 | -67.6% | 0.00% | -77.8% |
| Q3 2020 | $604,000 | +18.9% | 48,697 | +24.6% | 0.01% | 0.0% |
| Q2 2020 | $508,000 | – | 39,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,758,069 | $23,085,000 | 6.16% |
| Ally Bridge Group (NY) LLC | 700,000 | $5,859,000 | 5.34% |
| Kynam Capital Management, LP | 2,350,448 | $19,673,000 | 5.02% |
| Omega Fund Management, LLC | 1,500,000 | $12,555,000 | 4.01% |
| Ikarian Capital, LLC | 1,000,387 | $8,373,000 | 1.53% |
| HHLR ADVISORS, LTD. | 7,420,974 | $62,114,000 | 1.33% |
| Boxer Capital, LLC | 2,462,358 | $20,610,000 | 1.30% |
| Palo Alto Investors LP | 1,750,651 | $14,653,000 | 1.28% |
| Artal Group S.A. | 2,358,968 | $19,745,000 | 1.06% |
| Birchview Capital, LP | 159,088 | $1,332,000 | 0.97% |